Minimal hepatic encephalopathy

Indian Journal of Gastroenterology

Volumn 28, Issue 1, 2009, Pages 5-16

  Dhiman, Radha K ^a   Chawla, Yogesh K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Hepatic encephalopathy; Minimal HE; Minimal hepatic encephalopathy

Indexed keywords

AMMONIA; BENZOIC ACID; BRANCHED CHAIN AMINO ACID; CARNITINE; FLUMAZENIL; LACTULOSE; LEVACECARNINE; MANGANESE; ORNITHINE ASPARTATE; PLACEBO; PREBIOTIC AGENT; PROBIOTIC AGENT; RIFAXIMIN; SYNBIOTIC AGENT; YOGHURT;

ANAMNESIS; CAR DRIVING; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; DIAGNOSTIC PROCEDURE; DIET THERAPY; DIETARY FIBER; DISEASE SEVERITY; DRUG SAFETY; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; LIVER DYSFUNCTION; MENTAL HEALTH; NEUROPHYSIOLOGY; NOMENCLATURE; PATHOGENESIS; PATIENT COMPLIANCE; PHYSICAL EXAMINATION; PREVALENCE; PSYCHOMETRY; PSYCHOMOTOR DISORDER; QUALITY OF LIFE; RATING SCALE; REVIEW; SCREENING TEST; SURVIVAL RATE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME;

COGNITION; HEPATIC ENCEPHALOPATHY; HUMANS; LACTULOSE; PROBIOTICS; PSYCHOMETRICS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 67649600782     PISSN: 02548860     EISSN: 02548860     Source Type: Journal    
DOI: 10.1007/s12664-009-0003-6     Document Type: Review

References (101)

1. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002;35:716-721 (Pubitemid 34183979)
2. Mullen KD. Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy. Aliment Pharmacol Ther 2007;25 Suppl 1:11-16
3. Kharbanda PS, Saraswat VA, Dhiman RK: minimal hepatic encephalopathy: diagnosis by neurophchological and neurophysiological methods. Indian J Gastroenterol 2003;22(Suppl 2):537-541 (Pubitemid 38282250)
4. Ortiz M, Jacas C, Cordoba J. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. J Hepatol 2005;42 (Suppl 1):S45-53. (Pubitemid 40364603)
5. Rikkers L, Jenko P, Rudman D, Freides D. Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism. Gastroenterology 1978;75:462-469 (Pubitemid 9003354)
6. Schomerus H, Hamster W, Blunck H, Reinhard U, Mayer K, Doell W. Latent portasystemic encephalopathy. I. Nature of cerebral function defects and their effect on fitness to drive. Dig Dis Sci 1981;26:622-630
7. Zeegen R, Drinkwater JE, Dawson AM. Method for measuring cerebral dysfunction in patients with liver disease. Br Med J 1970;2:633-636
8. Rikkers L, Jenko P, Rudman D, Freides D. Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism. Gastroenterology 1978;75:462-469 (Pubitemid 9003354)
9. Amodio P, Del Piccolo F, Petteno E, et al. Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients. J Hepatol 2001;35: 37-45. (Pubitemid 32646222)
10. Nolte W, Wiltfang J, Schindler C, et al. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations. Hepatology 1998;28:1215-1225 (Pubitemid 28493830)
11. Boyer TD, Haskal ZJ, American Association for the Study of Liver Diseases. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology 2005;41:386-400.
12. Quero JC, Schalm SW. Subclinical hepatic encephalopathy. Semin Liver Dis 1996;16:321-328 (Pubitemid 27029881)
13. Romero-Gomez M, Boza F, Garcia-Valdecasas MS, García E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 2001;96:2718-2723 (Pubitemid 32889211)
14. Das A, Dhiman RK, Saraswat VA, Naik SR. Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis. J Gastroenterol Hepatol 2001;16:531-535 (Pubitemid 34188860)
15. Hartmann IJ, Groeneweg M, Quero JC, et al. The prognostic significance of subclinical hepatic encephalopathy. Am J Gastroenterol 2000;95:2029-2034 (Pubitemid 30629302)
16. Kircheis G, Wettstein M, Timmermann L, Schnitzler A, Haussinger D. Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology 2002;35:357-366 (Pubitemid 34106375)
17. Groeneweg M, Quero JC, De Bruijn I, et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998;28:45-49 (Pubitemid 28299984)
18. Groeneweg M, Moerland W, Quero JC, Hop WCJ, Krabbe P, Schalm SW. Screening of subclinical hepatic encephalopathy. J Hepatol 2000;32:748-753 (Pubitemid 30262734)
19. Quero JC, Hartmann IJC, Meulstee J, Hop WCJ, Schalm SW. The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropshychological tests and automated electroencephalogram analysis. Hepatology 1996;24:556-560 (Pubitemid 26295997)
20. Kurmi R, Reddy K, Dhiman RK, et al. Psychometric hepatic encephalopathy score, critical flicker frequency and p300 event-related potential for the diagnosis of minimal hepatic encephalopathy: Evidence that psychometric hepatic encephalopathy score is enough. Indian J Gastroenterol 2008;27 (Suppl 1): S1.
21. Sarin SK, Nundy S. Subclinical encephalopathy after portosystemic shunts in patients with non-cirrhotic portal fibrosis. Liver 1985;5:142-146 (Pubitemid 15021829)
22. Mínguez B, García-Pagán JC, Bosch J, et al. Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy. Hepatology 2006;43:707-714
23. Sharma P, Sharma BC, Puri V, Sarin SK. Minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction. Am J Gastroenterol 2008;103:1406-1412 (Pubitemid 351813914)
24. Sharma P, Sharma BC, Tyagi P, Kumar M, Sarin SK. Neuropsychological impairment in severe acute viral hepatitis is due to minimal hepatic encephalopathy. Liver Int 2008;29:260-264
25. Perry W, Hilsabeck RC, Hassanein TI. Cognitive dysfunction in chronic hepatitis C: a review. Dig Dis Sci 2008;53:307-321 (Pubitemid 351170036)
26. Citro V, Milan G, Tripodi FS, Gennari A, Sorrentino P, Gallotta G, et al. Mental status impairment in patients with West Haven grade zero hepatic encephalopathy: the role of HCV infection. J Gastroenterol 2007;42:79-82. (Pubitemid 46351428)
27. Weissenborn K, Krause J, Bokemeyer M, et al. Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy. J Hepatol 2004;41:845-885 (Pubitemid 39434316)
28. Hilsabeck RC, Hassanein TI, Carlson MD, Ziegler EA, Perry W. Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C. J Int Neuropsychol Soc 2003;9:847-854 (Pubitemid 37139014)
29. Hilsabeck RC, Hassanein TI, Ziegler EA, Carlson MD, Perry W. Effect of interferon-alpha on cognitive functioning in patients with chronic hepatitis C. J Int Neuropsychol Soc 2005;11:16-22. (Pubitemid 40394277)
30. Fontana RJ, Bieliauskas LA, Lindsay KL, et al. Cognitive function does not worsen during pegylated interferon and ribavirin retreatment of chronic hepatitis C. Hepatology 2007;45:1154-1163 (Pubitemid 46775777)
31. Butterworth RF. Pathophysiology of hepatic encephalopathy: a new look at ammonia. Metab Brain Dis 2002;17:221-227 (Pubitemid 36204752)
32. Vaquero J, Chung C, Blei AT. Brain edema in acute liver failure. A window to the pathogenesis of hepatic encephalopathy. Ann Hepatol 2003;2:12-22.
33. Takano T, Tian GF, Peng W, et al. Astrocyte-mediated control of cerebral blood flow. Nat Neurosci 2006;9:260-270 (Pubitemid 43164550)
34. Ahboucha S, Butterworth RF. The neurosteroid system: implication in the pathophysiology of hepatic encephalopathy. Neurochem Int 2008;52:575-587
35. Balata S, Damink SW, Ferguson K, et al. Induced hyperammonemia alters neuropsychology, brain MR spectroscopy and magnetization transfer in cirrhosis. Hepatology 2003;37:931-939 (Pubitemid 36401563)
36. Cordoba J, Alonso J, Rovira A, et al. The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation. J Hepatol 2001;35:598-604.
37. Lockwood AH, Yap EW, Wong WH. Cerebral ammonia metabolism in patients with severe liver disease and minimal HE. J Cereb Blood Flow Metab 1991;11:337-341
38. Kale RA, Gupta RK, Saraswat VA, et al. Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy. Hepatology 2006;43: 698-706.
39. Shawcross DL, Davies NA, Williams R, Jalan R. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol 2004;40:247-254 (Pubitemid 38115829)
40. Shawcross DL, Wright G, Olde Damink SW, Jalan R. Role of ammonia and inflammation in minimal hepatic encephalopathy. Metab Brain Dis 2007;22:125-138 (Pubitemid 46354829)
41. Das K, Singh P, Chawla Y, Duseja A, Dhiman RK, Suri S. Magnetic resonance imaging of brain in patients with cirrhotic and non-cirrhotic portal hypertension. Dig Dis Sci 2008;53:2793-2798
42. Rama Rao KV, Reddy PV, Hazell AS, Norenberg MD. Manganese induces cell swelling in cultured astrocytes. Neurotoxicology 2007;28:807-812 (Pubitemid 47058571)
43. Ortiz M, Cordoba J, Doval E, Jacas C, Pujadas F, Esteban R, Guardia J. Development of a clinical hepatic encephalopathy staging scale. Aliment Pharmacol Ther 2007;26:859-867 (Pubitemid 47346697)
44. Amodio P, Montagnese S, Gatta A, Morgan MY. Characteristics of minimal hepatic encephalopathy. Metab Brain Dis 2004;19:253-267 (Pubitemid 39361187)
45. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198
46. Venktaramarao SH, Mittal, Prabhakar S, Dhiman RK. Brain perfusion single photon emission computed tomography (SPECT) abnormalities in patients with minimal hepatic encephalopathy (abstract). J Gastroenterol Hepatol 2008; 23 (Suppl 5): A62.
47. Grover VP, Dresner MA, Forton DM, et al. Current and future applications of magnetic resonance imaging and spectroscopy of the brain in hepatic encephalopathy. World J Gastroenterol 2006;12:2969-2978 (Pubitemid 43811072)
48. Weissenborn K, Ennen JC, Schomerus H, Rückert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001;34:768-773 (Pubitemid 32488796)
49. Romero-Gómez M, Córdoba J, Jover R, et al. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology 2007;45:879-885 (Pubitemid 46631556)
50. Dhiman RK, Saraswat VA, Verma M, Naik SR. Figure connection test: A modified number connection test for the objective assessment of mental state in illiterates. J Gastroenterol Hepatol 1995;10:14-23.
51. Weissenborn K. PHES: one label, different goods?! J Hepatol 2008;49:308-312
52. Mardini H, Saxby BK, Record CO. Computerized psychometric testing in minimal encephalopathy and modulation by nitrogen challenge and liver transplant. Gastroenterology 2008;135:1582-1590
53. Wesnes KA, Ward T, McGinty A, Petrini O. The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers. Psychopharmacology 2000;152:353-361
54. Forton DM, Thomas HC, Murphy CA, et al. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 2002;35:433-439 (Pubitemid 34106386)
55. Sharma P, Sharma BC, Puri V, Sarin SK. Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy. J Hepatol 2007;47:67-73. (Pubitemid 46830721)
56. Bajaj JS, Hafeezullah M, Franco J, et al. Inhibitory control test for the diagnosis of minimal hepatic encephalopathy. Gastroenterology 2008;135:1591-1600.
57. Montoliu C, Piedrafita B, Serra MA, et al. IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy. J Clin Gastroenterol 2008 Jun 16. [Epub ahead of print].
58. Groeneweg M, Quero JC, De Bruijn I, et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998;28:45-49 (Pubitemid 28299984)
59. Prasad S, Dhiman RK, Duseja A, Chawla Y, Sharma A, Agarwal R. Lactulose improves cognitive functions and health-related quality of life in cirrhotic patients with minimal hepatic encephalopathy. Hepatology 2007;45: 549-559 (Pubitemid 46450607)
60. Schomerus H, Hamster W. Quality of life in cirrhotics with minimal hepatic encephalopathy. Metab Brain Dis 2001;16:37-41. (Pubitemid 33064035)
61. Bao ZJ, Qiu DK, Ma X, et al. Assessment of healthrelated quality of life in Chinese patients with minimal hepatic encephalopathy. World J Gastroenterol 2007;13: 3003-3008 (Pubitemid 47028892)
62. Arguedas MR, DeLawrence TG, McGuire BM. Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis. Dig Dis Sci 2003;48:1622-1626 (Pubitemid 36936700)
63. Cordoba J, Cabrera J, Lataif L, Pener P, Zee P, Blei AT. High prevalence of sleep disturbances in cirrhosis. Hepatology 1998;27:339-345 (Pubitemid 28081044)
64. Weissenborn K, Heidenreich S, Giewekemeyer K, Ruckert N, Hecker H. Memory function in early hepatic encephalopathy. J Hepatol 2003;39:320-325 (Pubitemid 37070247)
65. Schomerus H, Hamster W, Blunck H, Reinhard U, Mayer K, Dolle W. Latent portasystemic encephalopathy. I. Nature of cerebral functional defects and their effect on fitness to drive. Dig Dis Sci 1981;26:622-630
66. Watanabe A, Tuchida T, Yata Y, Kuwabara Y. Evaluation of neuropsychological function in patients with liver cirrhosis with special reference to their driving ability. Metab Brain Dis 1995;10:239-248
67. Srivastava A, Mehta R, Rothke SP, Rademaker AW, Blei AT. Fitness to drive in patients with cirrhosis and portal-systemic shunting: a pilot study evaluating driving performance. J Hepatol 1994;21:1023-1028
68. Wein C, Koch H, Popp B, Oehler G, Schauder P. Minimal hepatic encephalopathy impairs fitness to drive. Hepatology 2004;39:739-745 (Pubitemid 38337653)
69. Marotolli RA, Cooney LM, Wagner S, Doucette J, Tinetti ME. Predictors of automobile crashes and moving violations among elderly drivers. Ann Intern Med 1994;121:842-846
70. Bajaj JS, Hafeezullah M, Hoffmann RG, Saeian K. Minimal hepatic encephalopathy: a vehicle for accidents and traffic violations. Am J Gastroenterol 2007;102:1903-1909 (Pubitemid 47301540)
71. Bajaj JS, Hafeezullah M, Hoffmann RG, et al. Navigation skill impairment: another dimension of the driving difficulties in minimal hepatic encephalopathy. Hepatology 2008;47:596-604. (Pubitemid 351280728)
72. Romero-Gomez M, Boza F, Garcia-Valdecasas MS, Garcia E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 2001;96:2718-2723 (Pubitemid 32889211)
73. Amodio P, Del Piccolo F, Marchetti P, et al. Clinical features and survival of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests. Hepatology 1999;29:1662-1667 (Pubitemid 29247036)
74. Saxena N, Bhatia M, Joshi YK, Garg PK, Tandon RK. Auditory P300 event-related potentials and number connection test for evaluation of subclinical hepatic encephalopathy in patients with cirrhosis of the liver: a follow-up study. J Gastroenterol Hepatol 2001;16:322-327 (Pubitemid 32374849)
75. Saxena N, Bhatia M, Joshi YK, Garg PK, Dwivedi SN, Tandon RK. Electrophysiological and neuropsychological tests for the diagnosis of subclinical hepatic encephalopathy and prediction of overt encephalopathy. Liver 2002;22:190-197 (Pubitemid 34846356)
76. Yen CL, Liaw YF. Somatosensory evoked potentials and number connection test in the detection of hepatic encephalopathy. Hepatogastroenterology 1990;37:332-334 (Pubitemid 20212027)
77. Romero-Gomez M, Grande L, Camacho I, Benitez S, Irles JA, Castro M. Altered response to oral glutamine challenge as prognostic factor for overt episodes in patients with minimal hepatic encephalopathy. J Hepatol 2002;37:781-787 (Pubitemid 35404217)
78. Romero-Gomez M, Grande L, Camacho I. Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy. Hepatology 2004;39:939-943 (Pubitemid 38428932)
79. Dhiman RK, Solanki KK. Management of hepatic encephalopathy: Seen and Unseen. In: Medicine Update Vol 17; Ed YK Munjal. 2007; pp 259-271
80. de Bruijn KM, Blendis LM, Zilm DH, Carlen PL, Anderson GH. Effect of dietary protein manipulation in subclinical portal-systemic encephalopathy. Gut 1983;24:53-60. (Pubitemid 13170187)
81. Egberts EH, Schomerus H, Hamster W, Jurgens P. Branched chain amino acids in the treatment of latent portosystemic encephalopathy. A double-blind placebo-controlled crossover study. Gastroenterology 1985;88:887-895
82. Plauth M, Egberts EH, Hamster W, et al. Longterm treatment of latent portosystemic encephalopathy with branched-chain amino acids: a double blind placebo-controlled cross over study. J Hepatol 1993:17;308-314 (Pubitemid 23134926)
83. McClain CJ, Potter TJ, Kromhort JP, Zieve L. The effect of lactulose on psychomotor performance tests in alcoholic cirrhosis without over HE. J Clin Gastroenterol 1981;6:325-329
84. Morgan MY, Alonso M, Stanger LC. Lactilol and lactulose for treatment of subclinical HE in cirrhotic patients. J Hepatol 1989;8:208-217
85. Watanable A, Sakai T, Sato S, et al. Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy. Hepatology 1997;26:1410-1414 (Pubitemid 27520004)
86. Horsmans Y. Solbreux PM, Daenens C. Desager JP, Geubel AP. Lactulose improves psychometric testing in cirrhotic patients with subclinical encephalpathy. Aliment Pharmacol Ther 1997:11:165-170 (Pubitemid 27067349)
87. Quero JC, Groenweg M, Muelster J, Hop WCJ, Schalm SW. Does a low dose of lactulose improve quality of life in patients with liver cirrhosis. In: Record C, Al Mardini H, eds. Advances in Hepatic Encephalopathy & Metabolism in Liver Disease. New Castle Upon Tyne: Medical faculty, University of Newcastle upon Tyne; 1997; p. 459-465
88. Li Z, Zhang H, Hong Y. Clinical effect of lactulose in the treatment of subclinical hepatic encephalopathy. Zhongguo Zhong Xi Yi Jie He Za Zhi 1999;9:13-15
89. Dhiman RK, Sawhney MS, Chawla YK, Das G, Ram S, Dilawari JB. Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy. Dig Dis Sci 2000;45:1549-1552 (Pubitemid 30701607)
90. Yu-qiang N, Zheng Z, Yu-yuan L, Wei-hong S, Li P, Shou-jun D. Long-term efficacy of lactulose in patients with subclinical hepatic encephalopathy. Chin J Intern Med 2003;42:261-266
91. Kale RA, Gupta RK, Saraswat VA, et al. Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy. Hepatology 2006;43:698-706.
92. Amodio P, Marechtti P, Del Piccolo F, et al. The effect of flumazenil on subclinical psychometric or neurophysiological alterations in cirrhotic patients: a double blind placebo controlled study. Clin Physiol 1997;17:533-539 (Pubitemid 27448341)
93. Kircheis G, Nilius R, Held C, et al. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study. Hepatology 1997;25:1351-1360 (Pubitemid 27250753)
94. Malaguarnera M, Gargante MP, Cristaldi E, et al. Acetyl-L-carnitine treatment in minimal hepatic encephalopathy. Dig Dis Sci 2008;53:3018-3025
95. Liu Q, Duon ZP, Ha DK, Bengmark S, Kurtovic J, Riordan SM. Symbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 2004;39:1441-1449 (Pubitemid 38569067)
96. Bajaj JS, Saeian K, Christensen KM, et al. Probiotic yogurt for the treatment of minimal hepatic encephalopathy. Am J Gastroenterol 2008;103:1707-1715
97. Malaguarnera M, Greco F, Barone G, Gargante MP, Malaguarnera M, Toscano MA. Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, doubleblind, placebo-controlled study. Dig Dis Sci 2007;52: 3259-3265 (Pubitemid 47512537)
98. Sharma P, Sharma BC, Puri V, Sarin SK. An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy. Eur J Gastroenterol Hepatol 2008;20:506-511 (Pubitemid 351667890)
99. Dhiman RK, Chawla YK. Minimal hepatic encephalopathy: should we start treating it? Gastroenterology 2004;127:1855-1857
100. Dhiman RK, Chawla YK. Minimal hepatic encephalopathy: Time to recognise and treat. Trop Gastroenterol 2008;29:6-12.
101. Mullen KD, Ferenci P, Bass NM, Leevy CB, Keeffe EB. An algorithm for the management of hepatic encephalopathy. Semin Liver Dis 2007;27 (suppl 2):32-47. (Pubitemid 47311544)